Globalization of precision medicine programs in lung cancer: a health system challenge

Abstract

Precision medicine is an innovative approach to disease prevention and treatment that considers differences in people’s genes, injuries, environments, and lifestyles to target the right therapies to the right patients at the right time. In oncology, precision medicine uses genetic andmolecular information, tailoring treatment on the single patient profile, optimizing efficacy and minimizing toxicities.1 This approach is revolutionizing lung cancer diagnosis and treatment. However, despite widely adopted, its benefit in clinical practice still remains to be fully elucidated.